SCOPUS 정보 검색 플랫폼

Journal of Hepatology

Volumn 54, Issue 2, 2011, Pages 388-391

Insulin resistance and oxidative stress: Two therapeutic targets in non-alcoholic steatohepatitis

(2) Voican, Cosmin Sebastian a,b Perlemuter, Gabriel a,b,c

a INSERM (France)

b UNIVERSITÉ PARIS SACLAY (France)

c HÔPITAL ANTOINE BÉCLÈRE (France)

Author keywords

Glitazone; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; PIOGLITAZONE; PLACEBO;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; DIABETES MELLITUS; HUMAN; INSULIN RESISTANCE; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 78751575838 PISSN: 01688278 EISSN: None Source Type: Journal
DOI: 10.1016/j.jhep.2010.07.054 Document Type: Note

Times cited : (11)

References (14)

1
- 34249278818
- Nonalcoholic fatty liver disease: From pathogenesis to patient care
- G. Perlemuter, A. Bigorgne, A.-M. Cassard-Doulcier, and S. Naveau Nonalcoholic fatty liver disease: from pathogenesis to patient care Nat Clin Pract Endocrinol Metab 3 2007 458 469
- (2007) Nat Clin Pract Endocrinol Metab , vol.3 , pp. 458-469
- Perlemuter, G.¹ Bigorgne, A.² Cassard-Doulcier, A.-M.³ Naveau, S.⁴

2
- 77951874018
- Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
- A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
- (2010) N Engl J Med , vol.362 , pp. 1675-1685
- Sanyal, A.J.¹ Chalasani, N.² Kowdley, K.V.³ McCullough, A.⁴ Diehl, A.M.⁵ Bass, N.M.⁶

3
- 34547492488
- PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
- M.A. Bouhlel, B. Derudas, E. Rigamonti, R. Divart, J. Brozek, and S. Haulon PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties Cell Metab 6 2007 137 143
- (2007) Cell Metab , vol.6 , pp. 137-143
- Bouhlel, M.A.¹ Derudas, B.² Rigamonti, E.³ Divart, R.⁴ Brozek, J.⁵ Haulon, S.⁶

4
- 18144444592
- Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis
- M. Perez-Carreras, P. Del Hoyo, M.A. Martin, J.C. Rubio, A. Martin, and G. Castellano Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis Hepatology 38 2003 999 1007
- (2003) Hepatology , vol.38 , pp. 999-1007
- Perez-Carreras, M.¹ Del Hoyo, P.² Martin, M.A.³ Rubio, J.C.⁴ Martin, A.⁵ Castellano, G.⁶

5
- 0035991444
- In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
- S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J Hepatol 37 2002 56 62
- (2002) J Hepatol , vol.37 , pp. 56-62
- Seki, S.¹ Kitada, T.² Yamada, T.³ Sakaguchi, H.⁴ Nakatani, K.⁵ Wakasa, K.⁶

6
- 46349088361
- Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial
- V. Ratziu, P. Giral, S. Jacqueminet, F. Charlotte, A. Hartemann-Heurtier, and L. Serfaty Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial Gastroenterology 135 2008 100 110
- (2008) Gastroenterology , vol.135 , pp. 100-110
- Ratziu, V.¹ Giral, P.² Jacqueminet, S.³ Charlotte, F.⁴ Hartemann-Heurtier, A.⁵ Serfaty, L.⁶

7
- 33751545838
- A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
- L. Belfort, S.A. Harrison, K. Brown, C. Darland, J. Finch, and J. Hardies A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis N Engl J Med 355 2006 2297 2307
- (2006) N Engl J Med , vol.355 , pp. 2297-2307
- Belfort, L.¹ Harrison, S.A.² Brown, K.³ Darland, C.⁴ Finch, J.⁵ Hardies, J.⁶

8
- 33845336554
- Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis
- J.F. Dufour, C.M. Oneta, J.J. Gonvers, F. Bihl, A. Cerny, and J.M. Cereda Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis Clin Gastroenterol Hepatol 4 2006 1537 1543
- (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 1537-1543
- Dufour, J.F.¹ Oneta, C.M.² Gonvers, J.J.³ Bihl, F.⁴ Cerny, A.⁵ Cereda, J.M.⁶

9
- 53049101877
- Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
- G.P. Aithal, J.A. Thomas, P.V. Kaye, A. Lawson, S.D. Ryder, and I. Spendlove Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis Gastroenterology 135 2008 1176 1184
- (2008) Gastroenterology , vol.135 , pp. 1176-1184
- Aithal, G.P.¹ Thomas, J.A.² Kaye, P.V.³ Lawson, A.⁴ Ryder, S.D.⁵ Spendlove, I.⁶

10
- 47149086771
- Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
- V. Nobili, M. Manco, R. Devito, V. Di Ciommo, D. Comparcola, and M.R. Sartorelli Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial Hepatology 48 2008 119 128
- (2008) Hepatology , vol.48 , pp. 119-128
- Nobili, V.¹ Manco, M.² Devito, R.³ Di Ciommo, V.⁴ Comparcola, D.⁵ Sartorelli, M.R.⁶

11
- 73049090978
- Treatment of nonalcoholic fatty liver disease in children: TONIC trial design
- J.E. Lavine, J.B. Schwimmer, J.P. Molleston, A.O. Scheimann, K.F. Murray, and S.H. Abrams Treatment of nonalcoholic fatty liver disease in children: TONIC trial design Contemp Clin Trials 31 2010 62 70
- (2010) Contemp Clin Trials , vol.31 , pp. 62-70
- Lavine, J.E.¹ Schwimmer, J.B.² Molleston, J.P.³ Scheimann, A.O.⁴ Murray, K.F.⁵ Abrams, S.H.⁶

12
- 33847378451
- Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis
- G. Bjelakovic, D. Nikolova, L.L. Gluud, R.G. Simonetti, and C. Gluud Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis JAMA 297 2007 842 857
- (2007) JAMA , vol.297 , pp. 842-857
- Bjelakovic, G.¹ Nikolova, D.² Gluud, L.L.³ Simonetti, R.G.⁴ Gluud, C.⁵

13
- 77953229020
- L-Carnitine supplementation to diet: A new tool in treatment of nonalcoholic steatohepatitis - A randomized and controlled clinical trial
- M. Malaguarnera, M.P. Gargante, C. Russo, T. Antic, M. Vacante, and M. Malaguarnera l-Carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis - a randomized and controlled clinical trial Am J Gastroenterol 105 2010 1338 1345
- (2010) Am J Gastroenterol , vol.105 , pp. 1338-1345
- Malaguarnera, M.¹ Gargante, M.P.² Russo, C.³ Antic, T.⁴ Vacante, M.⁵ Malaguarnera, M.⁶

14
- 77954236167
- A multicentric, double-blind, randomised controlled trial (RCT) of high dose of ursodeoxycholic acid in patients with non-alcoholic steatohepatitis (NASH) [abstract]
- V. Ratziu, V. De Ledinghen, F. Oberti, P. Mathurin, C. Wartelle-Bladou, and C. Renou A multicentric, double-blind, randomised controlled trial (RCT) of high dose of ursodeoxycholic acid in patients with non-alcoholic steatohepatitis (NASH) [abstract] J Hepatol 50 2009 S21
- (2009) J Hepatol , vol.50 , pp. 21
- Ratziu, V.¹ De Ledinghen, V.² Oberti, F.³ Mathurin, P.⁴ Wartelle-Bladou, C.⁵ Renou, C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.